Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Exercise program to reduce frailty in older adults with heart disease

Tests guided physiotherapy exercises for frailty in older people with coronary heart disease.

Plain-language title generated from the registry record
Registry title: Improving Frailty in Patients With Stable Ischemic Heart Disease

Key facts

Where
Barcelona, SpainSee the site

Where in Spain

  • Primary Care CentersBarcelona, SpainNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Trial code
NCT07373119
Record updated
28 January 2026
Original description
The goal of this clinical trial is to improve the frailty in old patients who have a cardiac disease .Read full original descriptionShow less

Impact of a Program Aimed at Improving Frailty in Patients With Stable Ischemic Heart Disease in Primary Care: Fragicor Study

The goal of this clinical trial is to improve the frailty in old patients who have a cardiac disease .

Researchers will determine the improvement in the instability and the strength along twelve sessions based on guided exercises and mobility techniques made by physiotherapists. Research team will also evaluate the medications and diet, as well as laboratory and clinical tests.

Inclusion: Age ≥ 70 years; Diagnosis of coronary artery disease (International Classification Diseases (ICD)-10 I20-I25); Canadian Cardiovascular Society Class I; Low cardiovascular risk according to exclusion criteria.

Exclusion: Inability or refusal to provide informed consent (advanced dementia, severe psychiatric illness); Severe mobility-limiting conditions (Parkinson's disease, progressive neurological disorders, disabling joint disease); Recent (<6 months) unstable angina, myocardial infarction, coronary revascularization or angioplasty; Deep venous thrombosis or pulmonary embolism in the last 6 months; Recent stroke (<6 months); Heart failure in New York Heart Assocaition functional status (NYHA) III-IV; Symptomatic valvular heart disease; Left ventricular ejection fraction < 50%; Inability to perform protocol procedures.

ClinicalTrials.gov NCT07373119